Am J Med 124:1043–1050PubMedCrossRef 32 Rosen CJ, Klibanski A (2

Am J Med 124:1043–1050PubMedCrossRef 32. Rosen CJ, Klibanski A (2009) Bone, fat and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med 122:409–414PubMedCrossRef 33. Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW (2007) Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 92:1640–1646PubMedCrossRef 34. Ibrahim MM (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11:11–18PubMedCrossRef 35. Rosen CJ, Bouxsein ML (2006) Mechanisms of disease: is osteoporosis the obesity of bone. Nat Clin Pract Rheumatol 2:35–43PubMedCrossRef 36. Himes CL, Reynolds SL (2012) Effect of obesity

on falls, injury, and 17DMAG cell line disability. J Am Geriatr Soc 60:124–129PubMedCrossRef 37. Singh NA, Quine S, Clemson LM, Williams EJ, Williamson DA, Stravrinos TM,

Grady JN, Perry TJ, Lloyd BD, Smith EUR, Fiatarone Singh MA (2012) Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: a randomized controlled study. J Am Med Dir Assoc 13:24–30PubMedCrossRef 38. Landi find more F, Liperoti R, Fusco D, Mastropaolo S, Quattrociocchi D, Proia A, Tosato M, Bernabei R, Onder G (2012) Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 13:121–126PubMedCrossRef 39. Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, Bernabei R, Onder G (2012) Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 31:652–658PubMedCrossRef 40. Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, Nevitt M, Visser M, CB-5083 in vivo Kritchevsky S, Badinelli S, Harris T, Newman AB, Cauley J, Ferrucci L, Guralnik J (2011) Gait speed and survival in older adults. JAMA 305:50–58PubMedCrossRef 41. Chumlea WC, Cesari M, Evans WJ, Ferrucci L, Fielding RA,

Pahor M, Studenski S, Vellas B, Members, Farnesyltransferase IWGoSTF (2011) Sarcopenia: designing phase IIB trials. J Nutr Health Aging 15:450–455PubMedCrossRef 42. Siris E, Delmas PD (2008) Assessment of 10-year absolute fracture risk: a new paradigm with worldwide application. Osteoporos Int 19:383–384PubMedCrossRef 43. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397PubMedCrossRef 44. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57PubMedCrossRef 45. Kanis JA, Johnell O, Oden A, Borgstrom F, Johansson H, De Laet C, Jonsson B (2005) Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporos Int 16:6–14PubMedCrossRef 46.

Comments are closed.